PITTSBURGH, Pennsylvania — Cohera Medical Inc., which is developing a tissue adhesive for use in tummy-tuck surgeries, received a $10 million investment commitment, the first of what it hopes will lead to a $25 million Series C round.
ATS Medical reports first commercial use of sutureless aortic valve
MINNEAPOLIS, Minnesota — Cardiology device maker ATS Medical Inc. (NSDQ:ATSI) announced the completion of the first commercial implants of its recently cleared sutureless aortic valve.
Can Miromatrix “regenerate” Minnesota’s medical industry?
By Thomas Lee
MINNEAPOLIS, Minnesota– Miromatrix Inc. has one official employee, zero money, and nothing yet to develop, never mind sell. But make no mistake: Everyone wants a piece of it.
Hyland Software launches software for MEDITECH meaningful use
Hyland Software Inc. launched OnBase software to help small healthcare providers meaningfully use health information technology.
The OnBase software is designed to handle paper-based content that the MEDITECH healthcare information system doesn’t in an affordable, easy-to-manage way so healthcare providers can comply with new “meaningful use” rules.
Gambro acquires CHF Solutions
By Thomas Lee
BROOKLYN PARK, Minnesota–Gambro, a Denver-based medical device company, has agreed to purchase CHF Solutions Inc. for an undisclosed amount.
Synapse Biomedical aims to raise $1.2 million in Series C round
By Mary Vanac
OBERLIN, Ohio — Synapse Biomedical Inc. raised more than $433,000 from investors on its way to $1.2 million to repay debt and get ready to supply its diaphragm pacing technology to a new market: ALS patients.
CardioInsight raises $5.7 million for heart-mapping technology
By Mary Vanac
CLEVELAND, Ohio — CardioInsight Technologies Inc. raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology, according to a regulatory filing.
St. Jude Medical wins Japanese approval for spinal cord stimulation system
St. Paul, Minnesota —St. Jude Medical Inc. (NYSE:STJ) won Japanese regulatory approval to begin selling a spinal-cord stimulation system for patients suffering from chronic pain.
Cardiovascular Systems gets FDA nod for Phase 2 trial
St. Paul, Minnesota — Vascular device maker Cardiovascular Systems Inc. has received FDA approval to begin a Phase 2 trial of its Diamond 360 catheter system for patients with heart lesions.
CHF Solutions drums up $1.8 million
By Thomas Lee
BROOKLYN PARK, Minnesota– CHF Solutions Inc. raised $1.8 million from investors, according to documents filed with the Securities and Exchange Commission.
The company is seeking a total of $2.3 million from the sale of equity.
Minnesota group aims to bolster support for FDA’s 510(k) program
By Thomas Lee
MINNEAPOLIS, Minnesota — For months, the medical device community has been fretting over what they see as the Food & Drug Administration’s increasingly heavy-handed way of approving new technologies.